IDEX Biometrics ASA Information about the first exercise period for warrants (Warrants A) issued in connection with the Private Placement and Subsequent Offering
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE…
Ultimovacs ASA Reports Fourth Quarter 2024 Financial Results and Provides General Business Update
Oslo, January 31, 2025: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology company…
Ultimovacs ASA: Regarding the extraordinary general meeting on 9 January 2025
Oslo, 5 January 2025: Reference is made to the stock exchange notice…
IDEX Biometrics ASA Preliminary result of the Subsequent Offering
November 30, 2024 12:50 ET | Source: IDEX BIOMETRICS ASA Reference is…